Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system

por Rashid N, Koh HA, Baca HC, Lin KJ, Malecha SE, Masaquel A
Publicado 2016

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer

por Stenehjem DD, Yoo M, Unni SK, Singhal M, Bauer H, Saverno K, Quah C, Masaquel A, Brixner DI
Publicado 2014